Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Xeloda Medicare Part B Reimbursement Raised To 90% Of AWP

Executive Summary

Roche's oncologic Xeloda will be reimbursed at 90% of the average wholesale price under Medicare Part B

You may also be interested in...



Medicare Law Causes Roche To Hesitate On Oncology Price Increases

Roche and Genentech are holding off on price increases in their oncology portfolio to avoid causing more confusion about reimbursement rates, Roche said

Medicare Law Causes Roche To Hesitate On Oncology Price Increases

Roche and Genentech are holding off on price increases in their oncology portfolio to avoid causing more confusion about reimbursement rates, Roche said

Paraplatin, Gemzar Medicare Payments Will Increase April 1

The Centers for Medicare & Medicaid Services will significantly increase payment rates for three top-selling oncology brands effective April 1

Related Content

UsernamePublicRestriction

Register

PS043409

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel